DK0838223T3 - Hjerneødeminhibitor - Google Patents

Hjerneødeminhibitor

Info

Publication number
DK0838223T3
DK0838223T3 DK96919984T DK96919984T DK0838223T3 DK 0838223 T3 DK0838223 T3 DK 0838223T3 DK 96919984 T DK96919984 T DK 96919984T DK 96919984 T DK96919984 T DK 96919984T DK 0838223 T3 DK0838223 T3 DK 0838223T3
Authority
DK
Denmark
Prior art keywords
endothelin antagonist
treating
brain edemas
edemas
preventing
Prior art date
Application number
DK96919984T
Other languages
English (en)
Inventor
Mitsuyoshi Ninomiya
Yoshiyuki Matsuo
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0838223T3 publication Critical patent/DK0838223T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96919984T 1995-06-02 1996-05-29 Hjerneødeminhibitor DK0838223T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16006095 1995-06-02
PCT/JP1996/001438 WO1996038173A1 (fr) 1995-06-02 1996-05-29 Inhibiteur de l'oedeme cerebral

Publications (1)

Publication Number Publication Date
DK0838223T3 true DK0838223T3 (da) 2003-11-17

Family

ID=15707042

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919984T DK0838223T3 (da) 1995-06-02 1996-05-29 Hjerneødeminhibitor

Country Status (16)

Country Link
US (1) US5945448A (da)
EP (1) EP0838223B1 (da)
JP (1) JP4011114B2 (da)
KR (1) KR100399797B1 (da)
CN (1) CN1083261C (da)
AT (1) ATE245447T1 (da)
AU (1) AU700182B2 (da)
BR (1) BR9608413A (da)
CA (1) CA2218028C (da)
DE (1) DE69629195T2 (da)
DK (1) DK0838223T3 (da)
ES (1) ES2202449T3 (da)
PT (1) PT838223E (da)
TR (1) TR199701497T1 (da)
TW (1) TW460286B (da)
WO (1) WO1996038173A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482857B1 (en) 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
TWI232102B (en) 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP2007217438A (ja) * 2001-07-17 2007-08-30 Shionogi & Co Ltd 注射用医薬製剤
EP2298315A1 (en) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
WO2006098800A1 (en) 2005-01-14 2006-09-21 Airlite Plastics Co. Insulated foam panel forms
JP2009530284A (ja) * 2006-03-13 2009-08-27 エンサイシブ・ファーマシューティカルズ・インコーポレイテッド 拡張期心不全を治療するための方法と組成物
WO2008088727A2 (en) 2007-01-12 2008-07-24 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8080549B2 (en) 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8919067B2 (en) 2011-10-31 2014-12-30 Airlite Plastics Co. Apparatus and method for construction of structures utilizing insulated concrete forms
CA2801735C (en) 2012-01-13 2019-08-06 Bradley J. Crosby An apparatus and method for construction of structures utilizing insulated concrete forms
USD713975S1 (en) 2012-07-30 2014-09-23 Airlite Plastics Co. Insulative insert for insulated concrete form
US10787827B2 (en) 2016-11-14 2020-09-29 Airlite Plastics Co. Concrete form with removable sidewall
US11155995B2 (en) 2018-11-19 2021-10-26 Airlite Plastics Co. Concrete form with removable sidewall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2950616B2 (ja) * 1991-01-29 1999-09-20 塩野義製薬株式会社 トリテルペン誘導体
DE69400506T2 (de) * 1993-06-11 1997-02-13 Shionogi & Co Triterpenderivate und diese enthaltende Endothelinrezeptor Antagonisten
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists

Also Published As

Publication number Publication date
EP0838223A4 (en) 2001-04-25
ES2202449T3 (es) 2004-04-01
TR199701497T1 (xx) 1998-06-22
DE69629195D1 (de) 2003-08-28
DE69629195T2 (de) 2004-05-06
MX9708920A (es) 1998-03-31
CA2218028C (en) 2010-07-06
ATE245447T1 (de) 2003-08-15
WO1996038173A1 (fr) 1996-12-05
EP0838223A1 (en) 1998-04-29
CA2218028A1 (en) 1996-12-05
BR9608413A (pt) 1998-12-29
AU5844096A (en) 1996-12-18
US5945448A (en) 1999-08-31
CN1186441A (zh) 1998-07-01
KR19990008341A (ko) 1999-01-25
JP4011114B2 (ja) 2007-11-21
PT838223E (pt) 2003-12-31
TW460286B (en) 2001-10-21
EP0838223B1 (en) 2003-07-23
KR100399797B1 (ko) 2004-04-13
AU700182B2 (en) 1998-12-24
CN1083261C (zh) 2002-04-24

Similar Documents

Publication Publication Date Title
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
DK0838223T3 (da) Hjerneødeminhibitor
DE69413237T2 (de) Plättchenaggregationsinhibitoren
RU94044454A (ru) Ингибитор аутоимунных заболеваний
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
ES2110115T3 (es) Inhibidores de la agregacion de plaquetas.
ATE386523T1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
DK0804418T3 (da) Platelataggregationshæmmere
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
ATE160143T1 (de) 2-substituierte morpholin- und thiomorpholinderivate als gaba-b antagonisten
PL313037A1 (en) Phenoxphenylocyclopententenylohydroxyureas
AU2101792A (en) Methanoanthracene D2 dopamine antagonists
WO2024075070A3 (ko) 신규한 바이사이클릭 헤테로사이클릴 화합물 및 이의 용도